Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1986 Sep;22(3):287–292. doi: 10.1111/j.1365-2125.1986.tb02889.x

Acute haemodynamic effects of pinacidil in man.

D P Nicholls, J G Murtagh, M E Scott, P Morton, R G Shanks
PMCID: PMC1401124  PMID: 3768241

Abstract

The acute haemodynamic effects of i.v. pinacidil 0.2 mg kg-1 infused over 8 min were studied in 10 normotensive patients undergoing cardiac catheterisation. Mean arterial pressure fell from 94 +/- 3 mmHg (mean +/- s.e. mean) before infusion to 74 +/- 3 mmHg at 10 min after commencing infusion (P less than 0.001) and during this time heart rate increased from 75 +/- 4 to 106 +/- 7 beats min-1 (P less than 0.001). Significant changes were recorded until the end of the observation period (70 min after commencing infusion). Cardiac index increased from 3.2 +/- 0.2 to 4.0 +/- 0.2 l min-1 m-2 (P less than 0.001) and systemic vascular resistance fell from 16 +/- 1 to 10 +/- 1 units (P less than 0.001) at 10 min after commencing infusion. By the end of the observation period, the values had returned to pre-infusion levels. Only small changes in pulmonary haemodynamics were observed. These results indicate that pinacidil acts as a peripheral arteriolar vasodilator, and as such may have a role in the treatment of arterial hypertension and of cardiac failure.

Full text

PDF
287

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arrigoni-Martelli E., Nielsen C. K., Olsen U. B., Petersen H. J. N''-cyano-N-4-pyridyl-N'-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): a new, potent vasodilator. Experientia. 1980 Apr 15;36(4):445–447. doi: 10.1007/BF01975139. [DOI] [PubMed] [Google Scholar]
  2. Braunwald E. Vasodilator therapy--a physiologic approach to the treatment of heart failure. N Engl J Med. 1977 Aug 11;297(6):331–333. doi: 10.1056/NEJM197708112970609. [DOI] [PubMed] [Google Scholar]
  3. Carlsen J. E., Kardel T., Hilden T., Tangø M., Trap-Jensen J. Immediate central and peripheral haemodynamic effects of a new vasodilating agent Pinacidil (P1134) in hypertensive man. Clin Physiol. 1981 Aug;1(4):375–384. doi: 10.1111/j.1475-097x.1981.tb00905.x. [DOI] [PubMed] [Google Scholar]
  4. FREIS E. D., ROSE J. C., HIGGINS T. F., FINNERTY F. A., Jr, KELLEY R. T., PARTENOPE E. A. The hemodynamic effects of hypotensive drugs in man. IV. 1-Hydrazinophthalazine. Circulation. 1953 Aug;8(2):199–204. doi: 10.1161/01.cir.8.2.199. [DOI] [PubMed] [Google Scholar]
  5. Kardel T., Hilden T., Carlsen J., Trap-Jensen J. N"-Cyano-N-4-pyridyl-N'-1,2,2-trimethyl-propylguanidine, a new vasodilating agent: acute effect of blood pressure and pharmacokinetics in hypertensive patients. J Cardiovasc Pharmacol. 1981 Sep-Oct;3(5):1002–1007. doi: 10.1097/00005344-198109000-00010. [DOI] [PubMed] [Google Scholar]
  6. Koch-Weser J. Medical intelligence drug therapy. N Engl J Med. 1976 Aug 5;295(6):320–323. doi: 10.1056/NEJM197608052950606. [DOI] [PubMed] [Google Scholar]
  7. Mikkelsen E., Pedersen O. L. Comparison of the effects of a new vasodilator pinacidil and nifedipine on isolated blood vessels. Acta Pharmacol Toxicol (Copenh) 1982 Nov;51(5):407–412. doi: 10.1111/j.1600-0773.1982.tb01045.x. [DOI] [PubMed] [Google Scholar]
  8. Morris D. L., Wisneski J. A., Gertz E. W., Wexman M., Axelrod R., Langberg J. J. Potentiation by nifedipine and diltiazem of the hypotensive response after contrast angiography. J Am Coll Cardiol. 1985 Oct;6(4):785–791. doi: 10.1016/s0735-1097(85)80483-6. [DOI] [PubMed] [Google Scholar]
  9. Nicholls D. P., McNeill J., Harron D. W., Shanks R. G. Cardiovascular effects of pinacidil and propranolol alone and in combination in normal humans. J Cardiovasc Pharmacol. 1986 Jan-Feb;8(1):51–54. doi: 10.1097/00005344-198601000-00008. [DOI] [PubMed] [Google Scholar]
  10. Nielsen C. K., Arrigoni-Martelli E. Effect of a new vasodilator, pinacidil (P 1134), on potassium, noradrenaline and serotonin induced contractions in rabbit vascular tissues. Acta Pharmacol Toxicol (Copenh) 1981 Nov;49(5):427–431. doi: 10.1111/j.1600-0773.1981.tb00927.x. [DOI] [PubMed] [Google Scholar]
  11. Olsen U. B., Arrigoni-Martelli E. Vascular effects in dogs of pinacidil (P 1134), a novel vasoactive antihypertensive agent. Eur J Pharmacol. 1983 Apr 8;88(4):389–392. doi: 10.1016/0014-2999(83)90591-5. [DOI] [PubMed] [Google Scholar]
  12. Partridge J. B., Robinson P. J., Turnbull C. M., Stoker J. B., Boyle R. M., Morrison G. W. Clinical cardiovascular experiences with iopamidol: a new non-ionic contrast medium. Clin Radiol. 1981 Jul;32(4):451–455. doi: 10.1016/s0009-9260(81)80301-7. [DOI] [PubMed] [Google Scholar]
  13. Ward J. W., McBurney A., Farrow P. R., Sharp P. Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator. Eur J Clin Pharmacol. 1984;26(5):603–608. doi: 10.1007/BF00543493. [DOI] [PubMed] [Google Scholar]
  14. Ward J. W. Pinacidil monotherapy for hypertension. Br J Clin Pharmacol. 1984 Aug;18(2):223–225. doi: 10.1111/j.1365-2125.1984.tb02456.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES